Lourdes Felix

CEO, CFO, and Director

Lourdes Felix is a female Hispanic entrepreneur and corporate finance executive with 30 years of combined experience in capital markets, public accounting and in the private sector. She presently serves as Chief Executive Officer, Chief Financial Officer and Director of BioCorRx Inc. (OTCQB: BICX), a leader in addiction treatment solutions and related disorders.  She has been with BioCorRx since October 2012. Lourdes is one of the founders and President of BioCorRx Pharmaceuticals Inc., a majority owned subsidiary of BioCorRx Inc. She has been instrumental in capital procurement, completing multi-million dollar equity financing and accomplished in structuring and negotiating transactions and favorable terms with investment banks. Along with other executives of the company, rebranded the Company and restructured and expanded the business model to position it for long term growth in the addiction treatment space and drug development. Extensive experience with clinic operations management. 

Prior to joining BioCorRx her experience was in the private sector, public accounting including audit and public company experience.  She has expertise in finance, accounting, budgeting and internal control principals including GAAP, SEC, and SOX Compliance. Thorough knowledge of federal and state regulations. Successfully managed and produced SEC regulatory filings. She has extensive experience in developing and managing financial operations. Lourdes has provided treasury and cash management functions. Excellent leader with a track record of documented contributions leading to improved financial performance, heightened productivity, and enhanced internal controls. Led corporate relationships with various major accounting firms and attorneys in preparing SEC filings and audited financial statements. Lourdes is very active in the Hispanic community and speaks fluent Spanish. Lourdes holds a Bachelor of Science degree in Accounting from University of Phoenix. She is an MBA candidate at D’Amore-McKim School of Business, Northeastern University.

Louis Lucido

President & Director

Mr. Lucido was formerly the Senior Advisor and Chief Operating Officer of DoubleLine Group, LP, a large investment firm with over $100 billion in assets under management. He was previously at TCW, where he served as a Group Managing Director. Prior to joining TCW in 2001, Mr. Lucido was the Chief Investment Officer for Delphi Financial Group (DFG) and was on several subsidiary Boards. Before DFG, he was the Chief Operating Officer and Secretary for Hyperion Capital Management and was also a Member of the Resolution Trust Advisory Committee. From 2013-2018, he served as a Member of the Board of Directors of CASA of Los Angeles and Chair. He served as a former member of the board for National CASA from 2018-2024. Mr. Lucido formerly served on the Boards of Junior Achievement, Southern California, 826LA, and the Lupus Research Alliance (formerly the Alliance for Lupus Research). Mr. Lucido received his MBA in Management and Finance from New York University and was a Member of the Dean’s Advisory Board of the N.Y.U. Stern School of Business.

Dr. Joseph DeSanto

Medical Director Consultant

Dr. Joe De Santo has over 25 years of experience in addiction medicine.  Dr. De Santo is board certified in both internal medicine and addiction medicine. He specializes in detox and has worked with several addiction treatment centers, holding various titles and treating thousands of patients in residential and acute levels of care. He has also worked in private practice since 2012.

Dr. De Santo’s own recovery journey and the doctors that cared for him in treatment led him to this work. He saw an opportunity to make a difference in people’s lives who need a unique type of physician and treatment in the relatively new specialty of addiction medicine. The gratitude of his patients and knowing that their recovery helps the whole family begin healing from the disease of addiction is what he finds most rewarding about this work. In his free time, Joe De Santo enjoys traveling, spending time with family, hiking, golfing, biking, and practicing yoga and Transcendental Meditation. Sobriety is at the core of his life, and he protects it above all else.  Dr. De Santo is an active participant in his 12-step community, sponsors other members, and attends meetings several times a week.

Dr. John Dombrowski

Medical Director Consultant

Dr. John F. Dombrowski, M.D., FASA is a highly respected, board-certified anesthesiologist with more than 25 years of experience in interventional pain management and addiction medicine. A native Washingtonian, Dr. Dombrowski began his academic journey at the University of Richmond, graduating with honors with a degree in biology and a minor in chemistry. He then earned a Master’s degree in physiology from Georgetown University before completing his medical degree at Georgetown University School of Medicine in 1989. He went on to complete his residency in anesthesiology at Yale University.

Dr. Dombrowski initially practiced traditional operating room anesthesiology but soon followed his enduring interest in the management of acute and chronic pain by establishing a private practice in Northwest Washington, D.C. His clinic serves patients who have not found relief through conventional therapies and emphasizes a patient-centered, multidisciplinary approach to care. His clinical focus includes minimally invasive, image-guided procedures that reduce pain, restore function, and minimize dependence on long-term opioid therapy.

His medical expertise encompasses a broad range of conditions, including spinal disorders, neuropathic pain, and musculoskeletal injuries. In addition to his interventional pain work, Dr. Dombrowski is deeply committed to the ethical and evidence-based treatment of substance use disorders. He serves as the medical director of three methadone treatment programs and a detoxification facility, where he provides integrated care combining medical therapy, behavioral support, and patient education. His approach reflects a strong understanding of the complex emotional and psychological dimensions of chronic pain and addiction. His expertise has been featured on national platforms such as The Today Show, Good Morning America, One America News, and RT.

Dr. George Fallieras

Medical Director Consultant

Dr. George N. Fallieras comes from a family of physicians. Dr. Fallieras grew up in Tampa, Florida, and graduated Phi Beta Kappa from the University of Florida. He obtained his M.D. from the University of Tennessee, and did his residency training in New Orleans at the Tulane Health Science Center/Charity Hospital. Dr. Fallieras is double board certified in both Internal Medicine and Pediatrics. He has extensive emergency room, hospital inpatient, ICU, inpatient and outpatient detoxification, and outpatient recovery experience. He has served as the Medical Director for multiple large Inpatient Hospitalist programs. He is passionate about international medicine and serves on twice yearly missions trips to rural Dominican Republic and Port-au-Prince, Haiti. Dr. Fallieras has served as expert commentary on multiple news, television, and radio outlets.

Dr. Fallieras has always taken a keen interest in addiction medicine, in particular alcohol and opiate abuse. He has provided care to countless alcoholic and addicted patients in the acute hospital setting. He has seen innumerable cases of suffering individuals literally drinking themselves to death. With dread, he has made those difficult calls to parents notifying them of their child’s overdose and death. He has witnessed the profound physical and emotional burden that alcohol and drug abuse inflicts upon the individual and their families. He has seen the disappointment and shame in the eyes of very good and determined individuals who desperately want to quit drinking but are held down by the firm grasp of addiction. Like most people, he has first-hand knowledge of family members and loved ones who have endured this common struggle.

As a medical director for BioCorRx, he has established ethical and effective protocols. He believes addiction is a chronic “brain disease” and requires comprehensive treatment including physical and laboratory evaluation, vitamin and nutrient repletion, nutritional support, safe and comfortable detoxification, medications to eliminate or reduce cravings, psychological attention, emotional regulation, behavioral modification to identify/address/avoid/extinguish triggers, and long-term attention and surveillance (group setting and support most effective).